The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grohmann, U.
Right arrow Articles by Puccetti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grohmann, U.
Right arrow Articles by Puccetti, P.
The Journal of Immunology, 2003, 171: 2581-2587.
Copyright © 2003 by The American Association of Immunologists

Functional Plasticity of Dendritic Cell Subsets as Mediated by CD40 Versus B7 Activation 1

Ursula Grohmann, Roberta Bianchi, Ciriana Orabona, Francesca Fallarino, Carmine Vacca, Alessandra Micheletti, Maria C. Fioretti and Paolo Puccetti2

Department of Experimental Medicine, University of Perugia, Perugia, Italy

Murine dendritic cells (DCs) can present Ag in an immunogenic or tolerogenic fashion, the distinction depending on either the occurrence of specialized DC subsets or the maturation or activation state of the DC. Although DC subsets may be programmed to direct either tolerance or immunity, it is not known whether appropriate environmental stimulation can result in complete flexibility of a basic program. Using splenic CD8- and CD8+ DCs that mediate the respective immunogenic and tolerogenic presentation of self peptides, we show that both the in vivo and in vitro activities of either subset can be altered by ligation of specific surface receptors. Otherwise immunogenic CD8- DCs become tolerogenic upon B7 ligation by soluble CTLA-4, a maneuver that initiates immunosuppressive tryptophan catabolism. In contrast, CD40 ligation on tolerogenic CD8+ DCs makes these cells capable of immunogenic presentation. Thus, environmental conditioning by T cell ligands may alter the default function of DC subsets to meet the needs of flexibility and redundancy.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
G. N. Scott, J. DuHadaway, E. Pigott, N. Ridge, G. C. Prendergast, A. J. Muller, and L. Mandik-Nayak
The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity
J. Immunol., June 15, 2009; 182(12): 7509 - 7517.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Curti, S. Trabanelli, V. Salvestrini, M. Baccarani, and R. M. Lemoli
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
Blood, March 12, 2009; 113(11): 2394 - 2401.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Orabona, M. T. Pallotta, C. Volpi, F. Fallarino, C. Vacca, R. Bianchi, M. L. Belladonna, M. C. Fioretti, U. Grohmann, and P. Puccetti
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis
PNAS, December 30, 2008; 105(52): 20828 - 20833.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Belladonna, C. Volpi, R. Bianchi, C. Vacca, C. Orabona, M. T. Pallotta, L. Boon, S. Gizzi, M. C. Fioretti, U. Grohmann, et al.
Cutting Edge: Autocrine TGF-{beta} Sustains Default Tolerogenesis by IDO-Competent Dendritic Cells
J. Immunol., October 15, 2008; 181(8): 5194 - 5198.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. L. Belladonna, U. Grohmann, P. Guidetti, C. Volpi, R. Bianchi, M. C. Fioretti, R. Schwarcz, F. Fallarino, and P. Puccetti
Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO
J. Immunol., July 1, 2006; 177(1): 130 - 137.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Orabona, P. Puccetti, C. Vacca, S. Bicciato, A. Luchini, F. Fallarino, R. Bianchi, E. Velardi, K. Perruccio, A. Velardi, et al.
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells
Blood, April 1, 2006; 107(7): 2846 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Delgado, E. Gonzalez-Rey, and D. Ganea
The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells
J. Immunol., December 1, 2005; 175(11): 7311 - 7324.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol., November 1, 2005; 17(11): 1429 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Braun, R. S. Longman, and M. L. Albert
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Blood, October 1, 2005; 106(7): 2375 - 2381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
X. Zhang, H. Huang, J. Yuan, D. Sun, W.-S. Hou, J. Gordon, and J. Xiang
CD4-8- Dendritic Cells Prime CD4+ T Regulatory 1 Cells to Suppress Antitumor Immunity
J. Immunol., September 1, 2005; 175(5): 2931 - 2937.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. K. H. Tan and H. C. O'Neill
Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
J. Leukoc. Biol., August 1, 2005; 78(2): 319 - 324.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Rossi and J. W. Young
Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity
J. Immunol., August 1, 2005; 175(3): 1373 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Orabona, M. L. Belladonna, C. Vacca, R. Bianchi, F. Fallarino, C. Volpi, S. Gizzi, M. C. Fioretti, U. Grohmann, and P. Puccetti
Cutting Edge: Silencing Suppressor of Cytokine Signaling 3 Expression in Dendritic Cells Turns CD28-Ig from Immune Adjuvant to Suppressant
J. Immunol., June 1, 2005; 174(11): 6582 - 6586.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M. L. Belladonna, M. C. Fioretti, D. V. Serreze, U. Grohmann, and P. Puccetti
CTLA-4-Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
J. Exp. Med., October 18, 2004; 200(8): 1051 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. Haase, K. Skak, B. K. Michelsen, and H. Markholst
Local Activation of Dendritic Cells Leads to Insulitis and Development of Insulin-Dependent Diabetes in Transgenic Mice Expressing CD154 on the Pancreatic {beta}-Cells
Diabetes, October 1, 2004; 53(10): 2588 - 2595.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Fallarino, C. Asselin-Paturel, C. Vacca, R. Bianchi, S. Gizzi, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Murine Plasmacytoid Dendritic Cells Initiate the Immunosuppressive Pathway of Tryptophan Catabolism in Response to CD200 Receptor Engagement
J. Immunol., September 15, 2004; 173(6): 3748 - 3754.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.